Dr. Tonning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Wisconsin Circle
Suite 700
Bethesda, MD 20815Phone+1 844-942-1789
Summary
- Dr. Tonning is a practicing physician and medical and pharmaceutical consultant. He is board-certified in Clinical Informatics and Occupational Medicine and also a licensed pharmacist. He has practiced medicine in various clinical settings and served as an Associate Director of Biomedical Informatics at the U.S. Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research.
Education & Training
- Johns Hopkins Bloomberg School of Public HealthResidency, Occupational and Environmental Medicine, 1994 - 1995
- Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 1992 - 1994
- Riverside Regional Medical CenterInternship, Transitional Year, 1991 - 1992
- Medical College of Georgia at Augusta UniversityClass of 1991
Certifications & Licensure
- FL State Medical License 2022 - 2025
- DC State Medical License 2020 - 2024
- VA State Medical License 2021 - 2024
- MD State Medical License 1993 - 2023
- American Board of Preventive Medicine Occupational Medicine
- American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- 22 citationsA dataset of 200 structured product labels annotated for adverse drug reactions.Dina Demner-Fushman, Sonya E. Shooshan, Laritza Rodriguez, Alan R. Aronson, François Michel Lang
Scientific Data. 2018-01-30 - 84 citationsUse of data mining at the Food and Drug AdministrationHesha J. Duggirala, Joseph M. Tonning, Ella Smith, Roselie A. Bright, John D. Baker
Journal of the American Medical Informatics Association. 2016-03-01 - 59 citationsEosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.Peter W. Kim, Alfred Sorbello, Ronald T. Wassel, Tracy M. Pham, Joseph M. Tonning
Drug Safety. 2012-12-13
Other Languages
- Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: